drugset / Trial / NCT00438139

Ph1 Marinol Interaction Study - Part 1 - 1

NCT00438139

Phase 1 Terminated 6 enrolled National Institute on Drug Abuse (NIDA)
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant interactions before conducting outpatient studies.

Timeline

Start
2007-03
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified Oral

Indications